MedTrace Logo

Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer

NCT00897845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2541

Last updated 2017-05-17

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at tumor samples from women who have undergone chemotherapy for breast cancer.

Conditions

Interventions

GENETIC

RNA analysis

GENETIC

microarray analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Brian Leyland-Jones, MD · Emory University

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-17
Primary Completion
2013-12-02
Completion
2013-12-02

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897845 on ClinicalTrials.gov